Expression of the HN, F, NP and M proteins of Sendai virus by recombinant vaccinia viruses and their contribution to protective immunity against Sendai virus infections in mice

References

1. Andrew M. E., Coupar B. E. H., Boyle D. B., Ada G. L. 1987; The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scandinavian Journal of Immunology 25:21–28
   [Google Scholar]
2. Buller R. M., Smith G. L., Cremer K., Notkins A. L., Moss B. 1985; Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature, London 317:813–815
   [Google Scholar]
3. Connors M., Collins P. L., Firestone C.-Y., Murphy B. R. 1991; Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. Journal of Virology 65:1634–1637
   [Google Scholar]
4. Elango N., Prince G. A., Murphy B. R., Venkatesan S., Chanock R. M., Moss B. R. 1986; Resistance to human respiratory syncytial virus infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences, U.S.A. 83:1906–1910
   [Google Scholar]
5. Endo A., Itamura S., Iinuma H., Funahashi S., Shida H., Koide F., Nerome K., Oya A. 1991; Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. Journal of General Virology 72:699–703
   [Google Scholar]
6. Fukumi H., Takeuchi Y. 1975; Vaccination against parainfluenza 1 virus (type muris) infection in order to eradicate this virus in colonies of laboratory animals. Developments in Biological Standardization 28:477–481
   [Google Scholar]
7. Gotoh H., Shioda T., Sakai Y., Mizumoto K., Shibuta H. 1989; Rescue of Sendai virus from ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes. Virology 171:434–443
   [Google Scholar]
8. Hidaka Y., Kanda T., Iwasaki K., Nomoto A., Shioda T., Shibuta H. 1984; Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3′ proximal 1013 nucleotides of the F gene. Nucleic Acids Research 21:7965–7973
   [Google Scholar]
9. Ishida N., Homma M. 1978; Sendai virus. Advances in Virus Research 23:349–383
   [Google Scholar]
10. Itoh M., Tan D. M., Hayashi T., Mochizuki Y., Homma M. 1990; Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin. Journal of Virology 64:5660–5664
    [Google Scholar]
11. Johnson P. R. Jr, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. 1987; Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B : evaluation of the contributions of F and G glycoproteins to immunity. Journal of Virology 61:3163–3166
    [Google Scholar]
12. Kashiwazaki H., Homma M., Ishida N. 1965; Assay of Sendai virus by immunofluorescence and hemadsorbed cell-counting procedures. Proceedings of the Society for Experimental Biology and Medicine 120:134–138
    [Google Scholar]
13. Kast W. M., Roux L., Curran J., Blom H. J., Voordouw A. C., Meloen R. H., Kolakofsky D., Melief C. J. 1991; Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proceedings of the National Academy of Sciences, U.S.A. 88:283–287
    [Google Scholar]
14. Kimura Y., Aoki H., Shimokata K., Ito Y., Takano M., Hirabayashi N., Norrby E. 1979; Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture. Archives of Virology 61:297–304
    [Google Scholar]
15. King A. M. Q., Stott E. J., Langer S. J., Young K. K. Y., Ball L. A., Wertz G. W. 1987; Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. Journal of Virology 61:2885–2890
    [Google Scholar]
16. Kingsbury D. W. 1990; Paramyxoviridae and their replication. In Virology, 2nd edn. pp. 945–962 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
17. Kiyotani K., Takao S., Sakaguchi T., Yoshida T. 1990; Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology 177:65–74
    [Google Scholar]
18. Mackett M., Smith G. L., Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach vol 1 pp. 191–211 Edited by Glover D. M. Oxford & Washington, D.C.: IRL Press;
    [Google Scholar]
19. Nishikawa K., Isomura S., Suzuki S., Watanabe E., Hamaguchi M., Yoshida T., Nagai Y. 1983; Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318–330
    [Google Scholar]
20. Nishino Y., Niikura M., Suwa T., Onuma M., Gotoh B., Nagai Y., Mikami T. 1991; Analysis of the protective effect of the haemagglutinin-neuraminidase protein in Newcastle disease virus infection. Journal of General Virology 72:1187–1190
    [Google Scholar]
21. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. 1986; Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A. 83:7462–7466
    [Google Scholar]
22. Panicali D., Davis D. W., Weinberg R. L., Paoletti E. 1983; Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proceedings of the National Academy of Sciences, U.S.A. 80:5364–5368
    [Google Scholar]
23. Shioda T., Hidaka Y., Kanda T., Shibuta H., Nomoto A., Iwasaki K. 1983; Sequence of 3,687 nucleotides from the 3′ end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Research 11:7317–7330
    [Google Scholar]
24. Shioda T., Iwasaki K., Shibuta H. 1986; Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Research 14:1545–1563
    [Google Scholar]
25. Smith G. L., Murphy B. R., Moss B. 1983; Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences, U.S.A. 80:7155–7159
    [Google Scholar]
26. Spriggs M. K., Murphy B. R., Prince G. A., Olmsted R. A., Collins P. L. 1987; Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses : contributions of the individual proteins to host immunity. Journal of Virology 61:3416–3423
    [Google Scholar]
27. Stone J. D., Burnet F. M. 1946; The production of vaccinia haemagglutinin in rabbit skin. Australian Journal of Experimental Biology and Medical Science 24:9–13
    [Google Scholar]
28. Stott E. J., Ball L. A., Young K. K., Furze J., Wertz G. W. 1986; Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. Journal of Virology 60:607–613
    [Google Scholar]
29. Stott E. J., Taylor G., Ball L. A., Anderson K., Young K. K.-Y., King A. M. Q., Wertz G. W. 1987; Immune and histo-pathological responses in animal vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
    [Google Scholar]
30. Tashiro M., Homma M. 1985; Protection of mice from wild-type Sendai virus by a trypsin-resistant mutant, TR-2. Journal of Virology 53:228–234
    [Google Scholar]
31. Tozawa H., Komatsu H., Ohkata K., Nakajima T., Watanabe M., Tanaka Y., Arifuku M. 1986; Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus. Archives of Virology 91:145–161
    [Google Scholar]
32. Warren L. 1959; The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry 234:1971–1975
    [Google Scholar]
33. Wertz G. W., Stott E. J., Young K. K. Y., Anderson K., Ball L. A. 1987; Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. Journal of Virology 61:293–301
    [Google Scholar]